CD19 and acute lymphoblastic leukemia: This resulted in the complete abrogation of EV‐mediated cytotoxicity and degradation of CD19/EV (Figure 4b,c; Figure S25, Supporting Information), indicating that the EV/CD19 complexes are also ultimately targeted to the lysosomes for degradation in B‐ALL target cells.